Ms. Moira Ong reports

PROMINO PROVIDES UPDATE RESPECTING PRIVATE PLACEMENT

Promino Nutritional Sciences Inc., further to its news release dated March 13, 2026, is progressing toward completion of a non-brokered private placement for up to $1.2-million in gross proceeds, through the issuance of up to 40 million units of the company at a price of three cents per unit. Each unit will consist of one common share and one-half of one common share purchase warrant, with each warrant being exercisable to purchase one additional share at a price of six cents for 12 months from the date of issuance.

The company may pay finders' fees in connection with the offering, as permitted by applicable securities laws and the rules of the Canadian Securities Exchange.

The company intends to use the net proceeds from the offering: (a) to finance inventory production; and (b) for general corporate purposes, excluding accrued salaries to officers or directors of the company, and payment for investor relations activities (as such term is defined in the policies of the Canadian Securities Exchange).

The offering is subject to execution of subscription agreements by the placees and to certain conditions, including, but not limited to, the receipt of all necessary regulatory approvals, including the approval of the Canadian Securities Exchange.

All securities issued in connection with the offering will be subject to a four-month-and-one-day statutory resale restriction pursuant to applicable Canadian securities laws.

Share cancellation clarification

The company also provides further clarification respecting its April 8, 2026, news release announcing the cancellation of two million common shares of the company. In August, 2024, pursuant to Promino's acquisition of Helios Helium Corp. by way of a three-cornered amalgamation, the company indirectly acquired all of the investments owned by Helios, which included two million common shares of Promino itself. On April 1, 2026, following approval of the company's board of directors, such shares were returned to treasury and subsequently cancelled, resulting in a two-million-share decrease in the number of issued outstanding common shares of the company.

About Promino Nutritional Sciences Inc.

Promino Nutritional Sciences is a Canadian innovation company focused on science-based, clinically proven nutrition for muscle health and recovery. Its core product, Rejuvenate Muscle Health, is a clinically researched amino acid formula designed to rebuild, restore and rejuvenate muscle tissue.

The company also produces Promino -- NSF Certified for Sport, trusted by elite athletes. Promino's ambassadors include Stanley Cup champion Jack Eichel (Vegas Golden Knights) and MLB legend Jose Bautista.

We seek Safe Harbor.